Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of

Fabrizio D'Ascenzo1, Umberto Barbero2, Claudio Moretti1

  • 1Division of Cardiology, University of Turin, Italy; Meta-analysis and Evidence based medicine Training in Cardiology (METCARDIO), Italy.

Insights

Percutaneous coronary intervention (PCI) reduces stroke risk compared to coronary artery bypass grafting (CABG), especially in women. However, PCI increases revascularization risk, particularly for women and diabetic patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are revascularization strategies for stable angina.
  • Their comparative effectiveness regarding mortality and myocardial infarction is established, but clinical variable impact on risk-benefit is unclear.

Purpose of the Study:

  • To assess the impact of clinical variables on the risk-benefit profile of PCI versus CABG in stable angina.
  • To evaluate outcomes including death, myocardial infarction, repeat revascularization, and stroke.

Main Methods:

  • Meta-regression analysis of 20 randomized clinical trials (RCTs) involving 12,844 patients.
  • Event rates were analyzed to determine interactions between baseline clinical features and revascularization choice.

Main Results:

  • PCI significantly reduced stroke risk compared to CABG (30-day OR 0.36, follow-up OR 0.57).
  • Stroke reduction with PCI was more pronounced in female patients.
  • PCI was associated with higher repeat revascularization rates, especially in women and diabetic patients.

Conclusions:

  • PCI offers a significant stroke risk reduction over CABG, particularly beneficial for women.
  • The increased risk of repeat revascularization with PCI necessitates careful consideration, especially in female and diabetic populations.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
709
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522